🚨 BREAKING: TARIFF RATE ON EU PHARMA PRODUCTS WILL BE 15% -- NOT THE FULL 100% THAT TRUMP ANNOUNCED LAST NIGHT $HIMS $NVO $LLY

$HIMS $NVO $LLY 🚨 503B GLP-1 TIRZEPATIDE UPDATE ProRx -- one of the 503B facilities that is producing tirzepatide again for the first time since the end of the shortage -- was recently inspected by the FDA 👀 The author of the Reddit post below writes: "Which then brings up

$HIMS short interest is 37% right now Here are a few historical comps 🤯

$HIMS AT #8 ON THE IBD TOP 50 - WEEK OF SEP 29 🔥 h/t Kiwi Kapital

$HIMS feeling frisky in the overnight session 40% short interest MFN deadline tomorrow Testosterone just launched Menopause coming soon Big week loading

🚨 HOOOOOOOOLY $HIMS 🚨 NUMBER OF SHARES AVAILABLE TO SHORT JUST HIT A ***NEW INTRADAY ALL-TIME LOW*** 600K SHARES 40% SHORT INTEREST

$HIMS hello old friend $60 🥰

🚨 BREAKING: "MOST-FAVORED NATION" DRUG PRICE NEGOTIATIONS BETWEEN THE TRUMP ADMINISTRATION AND PHARMA COMPANIES ARE ONGOING EVEN THOUGH THE DEADLINE PASSED YESTERDAY Source: Washington Examiner $HIMS $LLY $NVO

🚨 BREAKING: WHITE HOUSE TO LAUNCH 'TRUMPRX' WEBSITE TO ALLOW PATIENTS TO BUY LOW-COST DRUGS (yes this is real) $HIMS $NVO $LLY

🚨 BREAKING: BANK OF AMERICA REITERATES $HIMS $28 PRICE TARGET, UNDERPERFORM RATING Early Q3 credit card data was solid, but BOFa says September weakness points to potential miss

A wise man once said: "Buy $HIMS when the weather gets cold, sell when the weather gets warm. Trade has worked the last 4 years." 50 degrees in Manhattan this morning Playoff baseball has arrived Pumpkin beer on tap Not financial advice

🚨 BREAKING: NADER KABBANI, WHO RECENTLY JOINED $HIMS AS CHIEF OPERATING OFFICER, IS MOVING TO AN ADVISORY ROLE Mike Chi promoted to COO Mike has been with $HIMS for nearly 5 years and has served as Chief Commercial Officer, Chief Marketing Officer, and Chief Growth Officer

IMPORTANT NOTE RE: THE FUTURE OF $HIMS HOUSE